Search research articles
Contact Us
Filters
Showing results (101-110 of 107) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 107 results.
Schizophrenia Research
|
November 7, 2022
Agoraphobic avoidance in patients with psychosis: Severity and response to automated VR therapy in a secondary analysis of a randomised controlled clinical trial
Daniel Freeman, Sinéad Lambe, Ushma Galal, et al.
The Lancet. Psychiatry
|
April 8, 2022
Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analyses
Daniel Freeman, Sinéad Lambe, Thomas Kabir, et al.
Psychological Medicine
|
April 3, 2023
The Oxford Agoraphobic Avoidance Scale
Sinead Lambe, Jessica C Bird, Bao Sheng Loe, et al.
Behavioural and Cognitive Psychotherapy
|
February 15, 2022
Understanding agoraphobic avoidance: the development of the Oxford Cognitions and Defences Questionnaire (O-CDQ)
Laina Rosebrock, Sinéad Lambe, Sophie Mulhall, et al.
Psychological Medicine
|
April 28, 2022
Virtual reality (VR) therapy for patients with psychosis: satisfaction and side effects
Daniel Freeman, Laina Rosebrock, Felicity Waite, et al.
The Lancet. Psychiatry
|
September 24, 2023
Automated virtual reality cognitive therapy versus virtual reality mental relaxation therapy for the treatment of persistent persecutory delusions in patients with psychosis (THRIVE): a parallel-group, single-blind, randomised controlled trial in England with mediation analyses
Daniel Freeman, Rachel Lister, Felicity Waite, et al.
BMJ Open
|
August 30, 2019
Automated virtual reality (VR) cognitive therapy for patients with psychosis: study protocol for a single-blind parallel group randomised controlled trial (gameChange)
Daniel Freeman, Ly-Mee Yu, Thomas Kabir, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 107) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 107 results.
Schizophrenia Research
|
November 7, 2022
Agoraphobic avoidance in patients with psychosis: Severity and response to automated VR therapy in a secondary analysis of a randomised controlled clinical trial
Daniel Freeman, Sinéad Lambe, Ushma Galal, et al.
The Lancet. Psychiatry
|
April 8, 2022
Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analyses
Daniel Freeman, Sinéad Lambe, Thomas Kabir, et al.
Psychological Medicine
|
April 3, 2023
The Oxford Agoraphobic Avoidance Scale
Sinead Lambe, Jessica C Bird, Bao Sheng Loe, et al.
Behavioural and Cognitive Psychotherapy
|
February 15, 2022
Understanding agoraphobic avoidance: the development of the Oxford Cognitions and Defences Questionnaire (O-CDQ)
Laina Rosebrock, Sinéad Lambe, Sophie Mulhall, et al.
Psychological Medicine
|
April 28, 2022
Virtual reality (VR) therapy for patients with psychosis: satisfaction and side effects
Daniel Freeman, Laina Rosebrock, Felicity Waite, et al.
The Lancet. Psychiatry
|
September 24, 2023
Automated virtual reality cognitive therapy versus virtual reality mental relaxation therapy for the treatment of persistent persecutory delusions in patients with psychosis (THRIVE): a parallel-group, single-blind, randomised controlled trial in England with mediation analyses
Daniel Freeman, Rachel Lister, Felicity Waite, et al.
BMJ Open
|
August 30, 2019
Automated virtual reality (VR) cognitive therapy for patients with psychosis: study protocol for a single-blind parallel group randomised controlled trial (gameChange)
Daniel Freeman, Ly-Mee Yu, Thomas Kabir, et al.
Page
of 11